rs61748550
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000350.3(ABCA4):c.1222C>T(p.Arg408Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000350.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA4 | NM_000350.3 | c.1222C>T | p.Arg408Ter | stop_gained | 9/50 | ENST00000370225.4 | NP_000341.2 | |
LOC124904222 | XR_007066231.1 | n.203-4390G>A | intron_variant, non_coding_transcript_variant | |||||
ABCA4 | XM_047416704.1 | c.1222C>T | p.Arg408Ter | stop_gained | 9/49 | XP_047272660.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.1222C>T | p.Arg408Ter | stop_gained | 9/50 | 1 | NM_000350.3 | ENSP00000359245 | P1 | |
ABCA4 | ENST00000649773.1 | c.1222C>T | p.Arg408Ter | stop_gained | 9/19 | ENSP00000496882 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251456Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135902
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461888Hom.: 0 Cov.: 34 AF XY: 0.0000275 AC XY: 20AN XY: 727246
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74294
ClinVar
Submissions by phenotype
not provided Pathogenic:4Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 20, 2024 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23953153, 25525159, 28947085, 30771335, 16103129, 23755871, 14709597, 11328725, 23891399, 30060493, 33369172, 33301772, 32619608, 35657619, 28118664, 35119454, 11846518) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change creates a premature translational stop signal (p.Arg408*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is present in population databases (rs61748550, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Stargardt disease or retinitis pigmentosa (PMID: 16103129, 23755871). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 99035). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Jun 26, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 21, 2016 | - - |
Severe early-childhood-onset retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2016 | - - |
Stargardt disease 3 Pathogenic:1
Pathogenic, no assertion criteria provided | research | Ophthalmo-Genetics Lab, Instituto de Oftalmologia Conde de Valenciana | - | - - |
Retinitis pigmentosa 19 Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 25, 2023 | The heterozygous p.Arg408Ter variant in ABCA4 was identified by our study, in the compound heterozygous state with a pathogenic variant (ClinVar Variation ID: 99288) and a known risk variant (ClinVar Variation ID: 99390), in one individual with retinal dystrophy. This individual also carried another pathogenic variant (ClinVar Variation ID: 99288) and a known risk variant (ClinVar Variation ID: 99390); however, the phase of these variants is unknown at this time. The p.Arg408Ter variant in ABCA4 has been previously reported in 13 unrelated individuals with autosomal recessive ABCA4-related retinopathy (PMID: 30771335, PMID: 14709597, PMID: 30060493, PMID: 33369172, PMID: 33301772, PMID: 32619608, PMID: 16103129, PMID: 23755871, PMID: 11846518) and segregated with disease in 2 affected relatives from one family (PMID: 16103129), but has been identified in 0.005% (1/19952) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs61748550). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of these 13 affected individuals (PMID: 30771335, PMID: 14709597, PMID: 30060493, PMID: 33369172, PMID: 33301772, PMID: 32619608, PMID: 16103129, PMID: 23755871, PMID: 11846518), 7 were compound heterozygotes who carried pathogenic or likely pathogenic variants in trans (PMID: 23755871, ClinVar Variation ID: 99224, 99283; PMID: 16103129, ClinVar Variation ID: 99084; PMID: 32619608, ClinVar Variation ID: 1065650; PMID: 33301772, ClinVar Variation ID: 99208; PMID: 33369172, ClinVar Variation ID: 854791; PMID: 30771335, ClinVar Variation ID: 7879), one was a compound heterozygote who carried a likely pathogenic variant with unknown phase (PMID: 11846518, ClinVar Variation ID: 99307), and 4 were compound heterozygotes who carried variants of uncertain significance in trans (PMID: 32619608, ClinVar Variation ID: 7888, 99265; PMID: 33301772; PMID: 30060493, ClinVar Variation ID: 866940), which increases the likelihood that the p.Arg408Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 99035) and has been interpreted as pathogenic by multiple submitters. This nonsense variant leads to a premature termination codon at position 408, which is predicted to lead to a truncated or absent protein. Loss of function of the ABCA4 gene is an established disease mechanism in autosomal recessive ABCA4-related retinopathy. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive ABCA4-related retinopathy. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3_VeryStrong (Richards 2015). - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 11, 2019 | - - |
Retinitis pigmentosa Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 28, 2023 | Variant summary: ABCA4 c.1222C>T (p.Arg408X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.6e-05 in 251456 control chromosomes. c.1222C>T has been reported in the literature in multiple individuals affected with Stargardt disease (e.g. Riveiro-Alvarez_2013) or other ABCA4-related retinopathy. These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 23755871). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at